NAD+ (500mg)
Energy Production & DNA Repair
500.000 ₫
Delivery method:
Single vial
500.000 ₫
NAD+ pen
650.000 ₫
NAD+ (nicotinamide adenine dinucleotide) is the central redox coenzyme of every living cell — required by every mitochondrial energy step, every sirtuin (longevity gene) and the entire DNA-damage repair machinery (PARP enzymes). Cellular NAD+ falls sharply with age, chronic inflammation and metabolic stress, and that decline is one of the most strongly evidenced drivers of mitochondrial dysfunction. Direct subcutaneous NAD+ bypasses the absorption losses and methylation tax of oral NR/NMN precursors, delivering a high-dose restoration of the redox pool in a single shot. Researched for energy, cognitive clarity, recovery and cellular repair capacity. Available as 500mg and 1,000mg multi-dose vials; the 1,000mg vial supports clinical-tier dosing protocols. Often paired with SS-31 and MOTS-c in the Mito Stack. Typically run 2–3× per week.
Dosage
50–100mg subcutaneously, 2–3× weekly — titrate up slowly. The 500mg and 1,000mg vials are multi-dose supplies, not single doses.
Duration of effect
Energy lift felt for several hours (plasma half-life: ~2-4 hours)
See full half-life table →Key Features
- Cellular energy boost
- DNA repair support
- Anti-aging properties
- Metabolic health
Includes key details, half-life data, usage notes and research sources.
Usage Instructions
Subcutaneous injection as recommended. Consult a healthcare professional for protocols tailored to your goals.
Research Highlights
- Backed by scientific research
- Manufactured to pharmaceutical standards
- Used in clinical research settings
- Established safety profile
Safety Information
- •Consult your healthcare provider before use
- •Not intended for pregnant or nursing women
- •Store properly according to instructions
- •Report any adverse effects to your healthcare provider
Source: Cell Metabolism - ScienceDirect
Clinical Research
NAD+ supplementation reversed age-related decline in mitochondrial function and improved cognitive performance in aging subjects.
Read full studyAdditional Research
Source: Martens et al., Nature Communications (2018)
In a 6-week placebo-controlled trial in healthy middle-aged and older adults, oral NAD+ precursor supplementation was well tolerated and significantly elevated whole-blood NAD+ — direct human evidence that NAD+ pools can be restored.
Read full study